Neumora and RayzeBio Aim for Over $200M Each in IPOs
Biotech companies Neumora and RayzeBio are planning to raise around $227 million and $206 million, respectively, in their upcoming IPOs on Nasdaq. Neumora, a neuroscience startup, aims to offer 14.7 million shares under the ticker "NMRA," while RayzeBio, a radiopharmaceuticals developer, plans to list as "RYZB" and offer 13.2 million shares.